Stay updated on Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Sign up to get notified when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:41:20.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:37:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown on the page, replacing the previous v3.4.0. This is a minor site update and does not modify any study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-02-06T09:15:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    UI text updates: Show glossary and Hide glossary options have been added, QC-related labels updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', and the 'No FEAR Act Data' wording adjusted. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-22T17:39:02.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added to the page. The previous Revision: v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-15T10:45:21.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Locations section updated to group sites under a centralized 'Locations' heading and to include Kentucky. The former 'Kentucky Locations' subsection has been removed.
    Difference
    0.2%
    Check dated 2025-12-17T20:25:56.000Z thumbnail image

Stay in the know with updates to Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the Lung Squamous Carcinoma Combo Trial: Afatinib + Pembrolizumab page.